logo

For the Inventor, By the Inventor

Brighton, MA, United States of America

Dale A Pelletier

This inventor holds 5 USPTO granted patents. Top assignees: Amoco Corporation, Vysis, Inc.. Active years: 1994-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dale A Pelletier. Retrieved from https://idiyas.com/inventor/dale-a-pelletier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Southborough, MA (US) (1996)
  • Brighton, MA (US) (1994 - 2002)

Company Filing History:

goldMedal4 out of 1,528 
 
Amoco Corporation
 patents
silverMedal1 out of 26 
 
Vysis, Inc.
 patents

Years Active: 1994-2002

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6482589 - Nucleic acid probes for the detection of genital mycoplasmas (2002-11-19),
2. 5843667 - Nucleic acid probes for the detection for genital mycoplasmas (1998-12-01),
3. 5569586 - Nucleic acid probes for the detection of bacteria of the genus (1996-10-29),
4. 5552279 - Nucleic acid probes for the detection of mycoplasma pneumoniae and (1996-09-03),
5. 5324632 - Nucleic acid probes and methods for detecting fungi (1994-06-28),

Title: The Innovations of Dale A. Pelletier

Introduction

Dale A. Pelletier is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of molecular biology, particularly in the detection of mycoplasmas. With a total of 5 patents, his work has had a considerable impact on medical diagnostics.

Latest Patents

Pelletier's latest patents include innovative nucleic acid probes designed for the detection of genital mycoplasmas. These nucleic acids, ranging from approximately 10 to 250 nucleotides, are capable of hybridizing to rRNA and rDNA of mycoplasma etiological agents. His work addresses critical health issues such as nongonococcal urethritis, pelvic inflammatory disease, and salpingitis, which are caused by mycoplasmas from the genital areas.

Career Highlights

Throughout his career, Dale A. Pelletier has worked with prominent companies such as Amoco Corporation and Vysis, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of molecular diagnostics.

Collaborations

Pelletier has collaborated with esteemed colleagues, including William G. Weisburg and Mitchell L. Sogin. These partnerships have further enhanced his research and contributions to the scientific community.

Conclusion

Dale A. Pelletier's work in the development of nucleic acid probes has significantly advanced the detection of mycoplasmas, showcasing his dedication to improving medical diagnostics. His contributions continue to influence the field and highlight the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…